
KROS
Healthcare · Biotechnology · $202.1M market cap
$10.30+0.22 (+2.2%)Nov 13, 4:26 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +16.0% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | -0.96 | 0.70 | +172.9% |
| Aug 3, 2026 | After the close | -1.25 | -1.45 | -16.0% |
| Apr 30, 2026 | Time not confirmed | -0.73 | -1.21 | -66.2% |
| Mar 4, 2026 | After the close | -0.45 | -0.86 | -91.1% |
| Nov 5, 2025 | After the close | -1.11 | -0.18 | +83.8% |
| Aug 6, 2025 | After the close | -1.13 | -0.76 | +32.7% |
| May 6, 2025 | After the close | 0.01 | 3.62 | +36100.0% |
| Feb 26, 2025 | Before the open | -0.43 | -1.14 | -167.0% |
| Nov 6, 2024 | After the close | -1.28 | -1.41 | -10.2% |
| Aug 7, 2024 | After the close | -1.25 | -1.25 | 0.0% |
| May 8, 2024 | Before the open | -1.33 | -1.21 | +9.0% |
| Feb 28, 2024 | After the close | -1.37 | -1.34 | +2.2% |
| Nov 6, 2023 | Before the open | -1.35 | -1.33 |
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. It develops rinvatercept, which acts as a ligand trap and inhibits the biological effects of myostatin and activin A in Phase 1 clinical trials for…
| +1.5% |
| Aug 7, 2023 | Before the open | -1.35 | -1.27 | +5.9% |
| May 4, 2023 | After the close | -1.14 | -1.26 | -10.5% |
| Mar 3, 2023 | After the close | -1.10 | -1.09 | +0.9% |
| Nov 3, 2022 | Before the open | -1.26 | -0.92 | +27.0% |
| Aug 4, 2022 | After the close | -1.07 | -1.13 | -5.6% |
| May 5, 2022 | Before the open | -0.86 | -1.01 | -17.4% |
| Mar 9, 2022 | After the close | -0.92 | -0.30 | +67.4% |
| Nov 4, 2021 | Before the open | -0.72 | -0.87 | -20.8% |
| Aug 5, 2021 | After the close | -0.65 | -0.67 | -3.1% |
| May 6, 2021 | After the close | -0.58 | -0.68 | -17.2% |
| Mar 25, 2021 | Before the open | -0.57 | -0.49 | +14.0% |
| Nov 10, 2020 | After the close | -0.59 | -0.60 | -1.7% |
| Aug 13, 2020 | Before the open | -0.67 | -0.62 | +7.5% |
| May 22, 2020 | Before the open | -0.80 | -5.11 | -538.8% |